{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:51:34Z","timestamp":1783633894402,"version":"3.55.0"},"reference-count":68,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2002,11,11]],"date-time":"2002-11-11T00:00:00Z","timestamp":1036972800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[2003,1,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We demonstrated previously that continuous administration of EM\u2010800, a SERM having pure antiestrogenic activity in the mammary gland and endometrium in combination with monthly radiotherapy caused a greater inhibition of human ZR 75 1 tumor growth in nude mice than either therapy used alone. To further optimize therapy, we have now examined the effect of various treatment sequences to determine the optimal treatment regimen in the same model. EM 800 was given at the maximally effective oral dose of 300 \u03bcg daily. External beam radiation therapy (RTX) was carried out (2 Gy\/tumor\/day, 5 days per week for 3 weeks) for a total of 30 Gy\/tumor delivered directly to the tumor while shielding the rest of the animal body. There was no evidence of RTX\u2010related morbidity. Continuous treatment with EM 800 was initiated either 3 weeks before or at the same time as RTX, immediately after RTX, or 3 weeks before and immediately after RTX. After 156 days of treatment, EM 800 alone caused a 75% decrease in average tumor area, an effect equivalent to that achieved by ovariectomy. RTX alone, on the other hand, caused a transient 30% decrease in tumor area regardless of treatment sequence, whereas combined treatment with EM 800 and RTX was superior to either treatment alone. Combined treatment with EM 800 and RTX both started on Day 1 caused the greatest (88%), most rapid (50% in 2 weeks) and sustained decrease in tumor size. The present data indicate that optimal reduction in breast tumor size is achieved by continuous administration of EM 800 and RTX started simultaneously on Day 1. \u00a9 2002 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ijc.10803","type":"journal-article","created":{"date-parts":[[2002,12,2]],"date-time":"2002-12-02T13:58:57Z","timestamp":1038837537000},"page":"268-276","source":"Crossref","is-referenced-by-count":5,"title":["Effect of treatment sequence with radiotherapy and the antiestrogen EM 800 on the growth of ZR 75 1 human mammary carcinoma in nude mice"],"prefix":"10.1002","volume":"103","author":[{"given":"Mathieu","family":"Gutman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steeve","family":"Couillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernand","family":"Labrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Candas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Labrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,11,26]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.52.1.23"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-4295(76)90301-0"},{"key":"e_1_2_6_4_2","first-page":"1","volume-title":"Estrogen receptors in human breast cancer","author":"McGuire WL","year":"1975"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-0760(99)00065-5"},{"key":"e_1_2_6_6_2","first-page":"151","article-title":"Basic guide to the mechanisms of antiestrogen action","volume":"50","author":"MacGregor JI","year":"1998","journal-title":"Pharmacol Rev"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.2.840"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.10.772"},{"key":"e_1_2_6_9_2","first-page":"4857","article-title":"Effect of the combined treatment with the pure antiestrogen EM\u2010800 and radiotherapy on the growth of human ZR\u201075\u20101 breast cancer xenografts in nude mice","volume":"59","author":"Couillard S","year":"1999","journal-title":"Cancer Res"},{"key":"e_1_2_6_10_2","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1210\/endo.139.5.5968","article-title":"Comparison of the effects of the new orally antiestrogen EM\u2010800 with ICI 182 780 and toremifene on estrogen\u2010sensitive parameters in the ovariectomized mouse","volume":"139","author":"Martel C","year":"1998","journal-title":"Endocrinology"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-0760(97)00192-1"},{"key":"e_1_2_6_12_2","first-page":"3494","article-title":"Blockade of the stimulatory effect of estrogens, OH\u2010tamoxifen, OH\u2010toremifene, droloxifene and raloxifene on alkaline phosphatase activity by the antiestrogen EM\u2010800 in human endometrial adenocarcinoma Ishikawa cells","volume":"57","author":"Simard J","year":"1997","journal-title":"Cancer Res"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19970926)73:1<104::AID-IJC16>3.0.CO;2-G"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19971127)73:5<735::AID-IJC21>3.0.CO;2-3"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.139.5.2645"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm970095o"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199707313370502"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1278-3218(99)80024-9"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(99)80053-3"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.3.1013"},{"key":"e_1_2_6_21_2","doi-asserted-by":"crossref","unstructured":"HanksGE LuJ MachtayM VenkatesanV PinoverW ByhardtR RosenthalSA.RTOG Protocol 92\u201002: a Phase III trial of the use of long term androgen suppression following neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate. 36th Annual Meeting of the American Society of Clinical Oncology. New Orleans LA 2000.","DOI":"10.1016\/S0360-3016(00)80021-8"},{"key":"e_1_2_6_22_2","first-page":"4325","article-title":"Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo","volume":"57","author":"Pederson LC","year":"1997","journal-title":"Cancer Res"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)11423-4"},{"key":"e_1_2_6_24_2","first-page":"5176","article-title":"Effects of the antiestrogen EM\u2010800 (SCH 57050) and cyclophosphamide alone and in combination on growth of human ZR\u201075\u20101 breast cancer xenografts in nude mice","volume":"59","author":"Gutman M","year":"1999","journal-title":"Cancer Res"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(20000201)85:3<424::AID-IJC20>3.0.CO;2-S"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0960-0760(96)00069-6"},{"key":"e_1_2_6_27_2","first-page":"4933","article-title":"Stimulation of cell proliferation and estrogenic response by adrenal C19\u2010\u03945\u2010steroids in the ZR\u201075\u20101 human breast cancer cell line","volume":"46","author":"Poulin R","year":"1986","journal-title":"Cancer Res"},{"key":"e_1_2_6_28_2","first-page":"3131","article-title":"Additive inhibitory effects of an androgen and the antiestrogen EM\u2010170 on estradiol\u2010stimulated growth of human ZR\u201075\u20101 breast tumors in athymic mice","volume":"51","author":"Dauvois S","year":"1991","journal-title":"Cancer Res"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0045(19990201)38:2<83::AID-PROS1>3.0.CO;2-B"},{"key":"e_1_2_6_30_2","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0022-5347(17)42879-5","article-title":"The value of testosterone deprivation in stage D1 carcinoma of the prostate","volume":"139","author":"Kramolowski EV","year":"1988","journal-title":"J Urol"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19931215)72:12 <3888::AID-CNCR2820721726>3.0.CO;2-B"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)35493-9"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)35244-8"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970815)80:4<732::AID-CNCR12>3.0.CO;2-U"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)09201-0"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900701)66:1<89::AID-CNCR2820660117>3.0.CO;2-G"},{"key":"e_1_2_6_37_2","first-page":"3583","article-title":"Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase","volume":"43","author":"Osborne CK","year":"1983","journal-title":"Cancer Res"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02303498"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0045(19980915)37:1<51::AID-PROS8>3.0.CO;2-B"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2184.1999.3250289.x"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117045"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000637-199805000-00008"},{"key":"e_1_2_6_43_2","first-page":"135","article-title":"Regulation of estrogen receptor and epidermal growth factor receptor by tamoxifen under high and low estrogen environments in MCF\u20107 cells grown in athymic mice","volume":"7","author":"Koibuchi Y","year":"2000","journal-title":"Oncol Rep"},{"key":"e_1_2_6_44_2","first-page":"610","article-title":"Novel compounds inhibit estrogen formation and action","volume":"52","author":"Labrie C","year":"1992","journal-title":"Cancer Res"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(84)90043-3"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01805977"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.133.2.571"},{"key":"e_1_2_6_48_2","first-page":"812","article-title":"Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse","volume":"48","author":"Gottardis MM","year":"1988","journal-title":"Cancer Res"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a058286"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)90717-3"},{"key":"e_1_2_6_51_2","first-page":"6929","article-title":"ICI 164,384, a pure antagonist of estrogen\u2010stimulated MCF\u20107 cell proliferation and invasiveness","volume":"49","author":"Thompson EW","year":"1989","journal-title":"Cancer Res"},{"key":"e_1_2_6_52_2","first-page":"157","article-title":"Hormone dependency and the action of tamoxifen in human mammary carcinoma cells","volume":"2","author":"Roos W","year":"1982","journal-title":"Anticancer Res"},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(84)90062-2"},{"key":"e_1_2_6_54_2","first-page":"349","article-title":"Effect of estradiol on human breast cancer cells in culture","volume":"43","author":"Darbre P","year":"1983","journal-title":"Cancer Res"},{"key":"e_1_2_6_55_2","first-page":"4355","article-title":"Proliferation, hormonal responsiveness, and estrogen receptor content of MCF\u20107 human breast cancer cells grown in the short\u2010term and long\u2010term absence of estrogens","volume":"47","author":"Katzenellenbogen BS","year":"1987","journal-title":"Cancer Res"},{"key":"e_1_2_6_56_2","first-page":"60","article-title":"Comparison of the effects of the antiestrogens EM\u2010800 and Tamoxifen on the growth of human breast ZR\u201075\u20101 cancer xenografts in nude mice","volume":"58","author":"Couillard S","year":"1998","journal-title":"Cancer Res"},{"key":"e_1_2_6_57_2","first-page":"1839","article-title":"Tamoxifen\u2010induced tumor stimulation and withdrawal response","volume":"63","author":"Legault\u2010Poisson S","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_6_58_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198937040-00004"},{"key":"e_1_2_6_59_2","first-page":"210","article-title":"Duration of adjuvant treatment with tamoxifen in patients with resectable breast cancer","volume":"126","author":"Davies C","year":"1998","journal-title":"Rev Med Chil"},{"key":"e_1_2_6_60_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008321415065"},{"key":"e_1_2_6_61_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2204::AID-CNCR15>3.0.CO;2-Y"},{"key":"e_1_2_6_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)55916-0"},{"key":"e_1_2_6_63_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.18.1371"},{"key":"e_1_2_6_64_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19971114)73:4<580::AID-IJC20>3.0.CO;2-C"},{"key":"e_1_2_6_65_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19971104)73:3<381::AID-IJC13>3.0.CO;2-G"},{"key":"e_1_2_6_66_2","unstructured":"CouillardS GutmanM LabrieC LabrieF.Effect of combined treatment using radiotherapy and the antiestrogen EM\u2010800 on ZR\u201075\u20101 human mammary carcinoma growth in nude mice. Proceedings of the 89th American Association of Cancer Research. New Orleans LA March 28\u2013April 1 1998."},{"key":"e_1_2_6_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(97)00309-X"},{"key":"e_1_2_6_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(89)90514-1"},{"key":"e_1_2_6_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)05036-9"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.10803","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.10803","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T05:02:52Z","timestamp":1697173372000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.10803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11,26]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,1,10]]}},"alternative-id":["10.1002\/ijc.10803"],"URL":"https:\/\/doi.org\/10.1002\/ijc.10803","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,11,26]]}}}